跳至主要内容
临床试验/NL-OMON38922
NL-OMON38922已完成不适用

Pharmacokinetic study of a new formulation of elacridar - Pharmacokinetic study of a new formulation of elacridar

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Healthy volunteer;
  • 2. Age >=18 years;
  • 3. Able and willing to give written informed consent;
  • 4. Able and willing to undergo blood sampling for pharmacokinetic sampling;
  • 5. Able and willing to swallow and retain oral medication;
  • 6. Willing to comply to the protocol

排除标准

  • 1. Any treatment with investigational drugs within two weeks prior to receiving the first dose of investigational treatment;

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验